SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-061598
Filing Date
2020-05-14
Accepted
2020-05-14 16:11:14
Documents
43
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014555d1_10q.htm 10-Q 304476
2 EXHIBIT 10.1 tm2014555d1_ex10-1.htm EX-10.1 7390
3 EXHIBIT 31 tm2014555d1_ex31.htm EX-31 8800
4 EXHIBIT 32 tm2014555d1_ex32.htm EX-32 3848
  Complete submission text file 0001104659-20-061598.txt   1575399

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT bpth-20200331.xml EX-101.INS 197283
6 XBRL TAXONOMY EXTENSION SCHEMA bpth-20200331.xsd EX-101.SCH 25114
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bpth-20200331_cal.xml EX-101.CAL 20661
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bpth-20200331_def.xml EX-101.DEF 51563
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE bpth-20200331_lab.xml EX-101.LAB 163700
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bpth-20200331_pre.xml EX-101.PRE 137182
Mailing Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401
Business Address 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX 77401 (832) 742-1357
BIO-PATH HOLDINGS INC (Filer) CIK: 0001133818 (see all company filings)

IRS No.: 870652870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36333 | Film No.: 20877856
SIC: 2834 Pharmaceutical Preparations